Brie Carter

Extended outflows from Bitcoin and Ether ETFs suggest institutions have pulled back from crypto, according to data and analysis from Glassnode.

Bybit will begin phasing out services for Japanese residents from 2026 as it moves to comply with the country’s strict cryptocurrency regulations.

Ice Open Network is rolling out its ION blockchain and Online+ social app to drive mainstream DApp adoption as it migrates from the ICE token.

Former FTX US president Brett Harrison has raised $35 million to build a regulated institutional trading platform spanning crypto, equities and derivatives markets.

Prediction market activity has surged as newly released Epstein documents fuel speculation, driving traders on Polymarket and Kalshi to place high-stakes bets based on public curiosity rather than confirmed legal outcomes.

Quantum BioPharma (NASDAQ:QNTM) has successfully completed oral dosing in both its 180-day repeated-dose toxicity and toxicokinetic studies for Lucid-21-302, its lead candidate for the treatment of multiple sclerosis (MS).

ZOOZ Strategy has been placed on a Nasdaq compliance clock after the exchange warned that its shares no longer meet the $1 minimum bid-price requirement, putting the company at risk of delisting if the price does not recover within six months.

Cipher Mining (NASDAQ:CIFR) has acquired a 200-megawatt development site in Ohio, marking its first major expansion outside of Texas as it pivots toward high-performance computing (HPC) and AI hosting.

Coya Therapeutics, (NASDAQ: COYA) announced today that Health Canada has accepted its Clinical Trial Application (CTA) for COYA 302, a potential breakthrough combination biologic for the treatment of Amyotrophic Lateral Sclerosis (ALS).

AtaiBeckley (NASDAQ:ATAI) saw its common stock added to the NASDAQ Biotechnology Index (NBI) prior to the market open on Dec. 22, 2025, marking a significant milestone in the company’s evolution as a leader in neuropsychiatric drug development.